Area of research
Physiology · Psychiatry and Mental health
Research interest
Research interests include Alzheimer's disease research and treatments, Dementia and Cognitive Impairment Research, Functional Brain Connectivity Studies, and Neuroinflammation and Neurodegeneration Mechanisms.
Phase 3 randomized clinical trials of simufilam in mild-to-moderate Alzheimer’s disease
Characterizing and validating 12-month reliable cognitive change in Early-Onset Alzheimer's Disease for use in clinical trials
Voiceprints of cognitive impairment: analyzing digital voice for early detection of Alzheimer’s and related dementias
Differences in baseline cognitive performance between participants with early‐onset and late‐onset Alzheimer's disease: Comparison of LEADS and ADNI
Varoglutamstat: Inhibiting Glutaminyl Cyclase as a Novel Target of Therapy in Early Alzheimer’s Disease
Two Phase 3 Trials of Gantenerumab in Early Alzheimer’s Disease
Amyloid and tau‐PET in early‐onset AD: Baseline data from the Longitudinal Early‐onset Alzheimer's Disease Study (LEADS)
The Sporadic Early‐onset Alzheimer's Disease Signature Of Atrophy: Preliminary Findings From The Longitudinal Early‐onset Alzheimer's Disease Study (LEADS) Cohort
Sex and <i>APOE ε4</i> carrier effects on atrophy, amyloid PET, and tau PET burden in early‐onset Alzheimer's disease
Pathogenic variants in the Longitudinal Early‐onset Alzheimer's Disease Study cohort
Profiling baseline performance on the Longitudinal Early‐Onset Alzheimer's Disease Study (LEADS) cohort near the midpoint of data collection
Cerebrospinal fluid biomarkers in the Longitudinal Early‐onset Alzheimer's Disease Study
Effect of AZD0530 on Cerebral Metabolic Decline in Alzheimer Disease
Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer’s disease
Genetic studies of plasma analytes identify novel potential biomarkers for several complex traits
A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease
Cognitive Impairment in Older Patients With Breast Cancer Before Systemic Therapy: Is There an Interaction Between Cancer and Comorbidity?
Cognitive Changes Preceding Clinical Symptom Onset of Mild Cognitive Impairment and Relationship to ApoE Genotype
Cognitive Effects of Cancer and Its Treatments at the Intersection of Aging: What Do We Know; What Do We Need to Know?